Skip to main content

Part of the book series: Handbuch Update-Seminar ((UPDATESEMINAR))

  • 1097 Accesses

Zusamenfassung

Im Folgenden sind die 2009 publizierten, als relevant bewerteten Originalarbeiten zusammengefasst. Um zu konklusiven Darstellungen zu kommen, mussten teilweise ältere Arbeiten angeführt werden, was aber in der Literaturzusammenfassung kenntlich gemacht wurde. Die Bewertungen der Arbeiten sind subjektiv, von eigenen Erfahrungen geprägt und in den meisten Fällen wissenschaftlich abgesichert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

7.7 Literatur

  1. Yan BM, Shaffer EA: Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009,58:721–732.

    Article  CAS  PubMed  Google Scholar 

  2. Korsapati H, Babaei A, Bhargava V, Dohil R, Quin A, Mittal RK: Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis. Gut 2009;58:1056–1062.

    Article  CAS  PubMed  Google Scholar 

  3. Rothenberg ME: Biology and treatment of eosinophilic esophagitis. Gastroenterology 2009, 137:1238–1249.

    Article  CAS  PubMed  Google Scholar 

  4. Odze RD: Pathology of eosinophilic esophagitis: what the clinician needs to know. Am J Gastroenterol 2009;104:485–490.

    Article  PubMed  Google Scholar 

  5. Okpara N, Aswad B, Baffy G: Eosinophilic colitis. World J Gastroenterol 2009;15:2975–2979.

    Article  PubMed  Google Scholar 

  6. Shaheen NJ, Richter JE: Barrett’s oesophagus. Lancet 2009;373:850–861.

    Article  CAS  PubMed  Google Scholar 

  7. Fiocca R, Mastracci L, Riddell R, Takubo K, Vieth M, Yerian L, Sharma P, Fernstrom P, Ruth M: Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol 2009.

    Google Scholar 

  8. Lang LH: Barrett’s Esophagus Survival Rates Same as in General Population. Gastroenterology 2009.

    Google Scholar 

  9. Cooper GS, Kou TD, Chak A: Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am. J. Gastroenterol. 2009;104:1356–1362.

    Article  PubMed  Google Scholar 

  10. Riddell RH, Odze RD: Definition of Barrett’s esophagus: time for a rethink — is intestinal metaplasia dead? Am J Gastroenterol 2009;104:2588–2594.

    Article  PubMed  Google Scholar 

  11. Odze RD: Barrett esophagus: histology and pathology for the clinician. Nat Rev Gastroenterol Hepatol 2009;6:478–490.

    Article  PubMed  Google Scholar 

  12. Liu W, Hahn H, Odze RD, Goyal RK: Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium. Am J Gastroenterol 2009,104:816–824.

    Article  CAS  PubMed  Google Scholar 

  13. Wang JS, Guo M, Montgomery EA, Thompson RE, Cosby H, Hicks L, Wang S, Herman JG, Canto Ml. DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett’s esophagus. Am J Gastroenterol. 2009 Sep;104(9):2153–60.

    Article  CAS  PubMed  Google Scholar 

  14. Sikkema M, Kerkhof M, Steyerberg EW, Küsters JG, van SPM Looman CW, van DH, Siersema PD, Kuipers EJ: Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett’s esophagus: a case-control study. Am J Gastroenterol 2009,104:2673–2680.

    Article  CAS  PubMed  Google Scholar 

  15. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB et al.:Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 2009;360:2277–2288.

    Article  CAS  PubMed  Google Scholar 

  16. Pouw RE, Gondrie JJ, Rygiel AM, Sondermeijer CM, ten KFJ, Odze RD, Vieth M, Krishnadath KK, Bergman JJ: Properties of the neosquamous epithelium after radiofrequency ablation of Barrett’s esophagus containing neoplasia. Am J Gastroenterol 2009;104:1366–1373.

    Article  PubMed  Google Scholar 

  17. Mandai RV, Fordone DG, Brugge WR, Nishioka NS, Mino-Kenudson M, Lauwers GY: Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia. Am J Surg Pathol 2009;33:620–625.

    Article  Google Scholar 

  18. Clarke AT, Wirz AA, Seenan JP, Manning JJ, Gillen D, McColl KE: Paradox of gastric cardia: it becomes more acidic following meals while the rest of stomach becomes less acidic. Gut 2009;58:904–909.

    Article  CAS  PubMed  Google Scholar 

  19. Freeman HJ: Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis. World J Gastroenterol 2008,14:1318–1320.

    Article  PubMed  Google Scholar 

  20. Carmack SW, Genta RM, Schuler CM, Saboorian MH: The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 2009, 104:1524–1532.

    Article  PubMed  Google Scholar 

  21. Carmack SW, Genta RM, Graham DY, Lauwers GY: Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol 2009, 6:331–341.

    Article  PubMed  Google Scholar 

  22. Murphy G, Pfeiffer R, Camargo MC, Rabkin CS: Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009,137:824–833.

    Article  PubMed  Google Scholar 

  23. Marrelli D, Pedrazzani C, Corso G, Neri A, Di MM, Pinto E, Roviello F: Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy. Ann Surg 2009;250:43–50.

    Article  PubMed  Google Scholar 

  24. Schuppan D, Junker Y, Barisani D: Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009,137:1912–1933.

    Article  CAS  PubMed  Google Scholar 

  25. Vilppula A, Kaukinen K, Luostarinen L, Krekela I, Patrikainen H, Valve R, Maki M, Collin P: Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol 2009;9:49.

    Article  PubMed  Google Scholar 

  26. Corazza GR, Villanacci V, Zambelli C, Milione M, Luinetti O, Vindigni C, Chioda C, Albarello L, Bartolini D, Donato F: Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin. Gastroenterol. Hepatol. 2007;5:838–843.

    Article  PubMed  Google Scholar 

  27. Armstrong MJ, Robins GG, Howdle PD: Recent advances in coeliac disease. Curr Opin Gastroenterol 2009;25:100–109.

    Article  CAS  PubMed  Google Scholar 

  28. Weir DC, Glickman JN, Roiff T, Valim C, Leichtner AM: Variability of histopathological changes in childhood celiac disease. Am J Gastroenterol 2010;105:207–212.

    Article  PubMed  Google Scholar 

  29. Thomas HJ, Ahmad T, Rajaguru C, Barnardo M, Warren BF, Jewell DP: Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand J Gastroenterol 2009;44:1076–1083.

    Article  PubMed  Google Scholar 

  30. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, Brantner TL, Kim WR, Phelps TK, Lahr BD, Zinsmeister AR, Melton LB, Murray JA: Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009, 137:88–93.

    Article  PubMed  Google Scholar 

  31. Virta LJ, Kaukinen K, Collin P: Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009;44:933–938.

    Article  PubMed  Google Scholar 

  32. Vande VJL, Murray JA, Lahr BD, Van DCT, Kroning CM, Moore SB, Wu TT: Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol 2009,104:142–148.

    Article  Google Scholar 

  33. Verdu EF, Armstrong D, Murray JA: Between celiac disease and irritable bowel syndrome: the “no man’s land” of gluten sensitivity. Am J Gastroenterol 2009,104:1587–1594.

    Google Scholar 

  34. Deretic V: Links between autophagy, innate immunity, inflammation and Crohn’s disease. Dig Dis 2009;27:246–251.

    Article  PubMed  Google Scholar 

  35. Hemminki K, Li X, Sundquist K, Sundquist J: Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am J Gastroenterol 2010;105:139–147.

    Article  PubMed  Google Scholar 

  36. Livia Biancone, Pierre Michetti, Simon Travis, Johanna C. Escher, Gabriele Moser, Alastair Forbes, Jörg C Hoffmann, Axel Dignass, Paolo Gionchetti, Günter Jantschek, Ralf Kiesslich, Sanja Kolacek, Rod Mitchell, Julian Panes, Johan Soderholm, Boris Vucelic, Eduard Stange: European evidence-based Consensus on the management of ulcerative colitis. Special situations 2008;2:63–92.

    Google Scholar 

  37. Soderlund S, Brandt L, Lapidus A, Karlen P, Brostrom O, Lofberg R, Ekbom A, Askling J: Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009,136:1561–7; quiz 1818-9.

    Article  PubMed  Google Scholar 

  38. Leedham SJ, Graham TA, Oukrif D, McDonald SA, Rodriguez-Justo M, Harrison RF, Shepherd NA, Novelli MR, Jankowski JA, Wright NA: Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 2009, 136:542–50.e6.

    Article  PubMed  Google Scholar 

  39. Moslein G: [Hereditary colorectal cancer]. Chirurg 2008;79:1038–1046.

    Article  CAS  PubMed  Google Scholar 

  40. Gomez GEB, Knoers NV: Gardner’s syndrome (familial adenomatous polyposis): a ciliarelated disorder. Lancet Oncol 2009,10:727–735.

    Article  Google Scholar 

  41. Terdiman JP: MYH-associated disease: attenuated adenomatous polyposis of the colon is only part of the story. Gastroenterology 2009,137:1883–1886.

    Article  CAS  PubMed  Google Scholar 

  42. Boparai KS, Dekker E, Van ES, Polak MM, Bartelsman JF, Mathus-Vliegen EM, Keller JJ, van NCJ: Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology 2008,135:2014–2018.

    Article  CAS  PubMed  Google Scholar 

  43. Nielsen M, Joerink-van dBM, Jones N, Vogt S, Tops CM, Vasen HF, Sampson JR, Aretz S, Hes FJ: Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology 2009,136:471–476.

    Article  CAS  PubMed  Google Scholar 

  44. Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, Steinke V, Vasen HF, Propping P, Sampson JR, Hes FJ, Aretz S: Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 2009,137:1976–85.e1-10.

    Article  CAS  PubMed  Google Scholar 

  45. Lefevre JH, Parc Y, Svrcek M, Kernels S, Colas C, Shields C, Flejou JF, Parc R, Tiret E: APC, MYH, and the correlation genotype-phenotype in colorectal polyposis. Ann Surg Oncol 2009,16:871–877.

    Article  PubMed  Google Scholar 

  46. Jones N, Vogt S, Nielsen M, Christian D, Wark PA, Eccles D, Edwards E, Evans DG, Maher ER, Vasen HF, Hes FJ, Aretz S, Sampson JR: Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 2009;137:489–94, 494.e1; quiz 725-6.

    Article  PubMed  Google Scholar 

  47. O’Shea AM, Cleary SP, Croitoru MA, Kim H, Berk T, Monga N, Riddell RH, Pollett A, Gallinger S: Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology 2008;53:184–194.

    Article  CAS  Google Scholar 

  48. Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB: Calculation of risk of colorectal and endometrial cancer among patients with. Gastroenterology 2009,137:1621–1627.

    Article  PubMed  Google Scholar 

  49. Jarrar AM, Church JM, Fay S, Kalady MF: Is the phenotype mixed or mistaken?. Hereditary nonpolyposis colorectal cancer and. Dis Colon Rectum 2009;52:1949–1955.

    PubMed  Google Scholar 

  50. Tannapfel A, Neid M, Aust D, Barretton G: Die Entstehung kolorektaler Karzinom — Unterschiedliche Wege und Vorstufen — differenziete Nomenklatur, in Press 2009.

    Google Scholar 

  51. Jass JR: Classification of colorectal cancer based on correlation of clinical. Histopathology 2007,50:113–130.

    Article  CAS  PubMed  Google Scholar 

  52. Makinen MJ: Colorectal serrated adenocarcinoma. Histopathology 2007;50:131–150.

    Article  CAS  PubMed  Google Scholar 

  53. Kumar S, Chang EY, Frankhouse J, Dorsey PB, Lee RG, Johnson N: Combination of microsatellite instability and lymphocytic infiltrate as a. Arch Surg 2009,144:835–840.

    Article  PubMed  Google Scholar 

  54. Koike M, Inada K, Nakanishi H, Matsuura A, Nakamura S, Tatematsu M: Cellular differentiation status of epithelial polyps of the colorectum: the gastric foveolar cell-type in hyperplastic polyps. Histopathology 2003;42:357–364.

    Article  CAS  PubMed  Google Scholar 

  55. Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM: Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003;27:65–81.

    Article  PubMed  Google Scholar 

  56. Rüschoff J, Aust D, Hartmann A: [Colorectal serrated adenoma: diagnostic criteria and clinical implications]. Verh Dtsch Ges Pathol 2007;91:119–125.

    PubMed  Google Scholar 

  57. Owens SR, Chiosea SI, Kuan S: Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod. Pathol. 2008;21:660–669.

    Article  CAS  PubMed  Google Scholar 

  58. Schmiegel W, Reinacher-Schick A, Arnold D, Graeven U, Heinemann V, Porschen R, Riemann J, Rodel C, Sauer R, Wieser M, Schmitt W, Schmoll HJ, Seufferlein T, Kopp I, Pox C: [Update S3-guideline “colorectal cancer” 2008]. Z Gastroenterol 2008;46:799–840.

    Article  CAS  PubMed  Google Scholar 

  59. Wong NA, Hunt LP, Novelli MR, Shepherd NA, Warren BF: Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology 2009;55:63–66.

    Article  PubMed  Google Scholar 

  60. Denis B, Peters C, Chapelain C, Kleinclaus I, Fricker A, Wild R, Auge B, Gendre I, Perrin P, Chatelain D, Flejou JF: Diagnostic accuracy of community pathologists in the interpretation of colorectal. Eur J Gastroenterol Hepatol 2009;21:1153–1160.

    Article  PubMed  Google Scholar 

  61. Tsikitis VL, Malireddy K, Green EA, Christensen B, Whelan R, Hyder J, Marcello P, Larach S, Lauter D, Sargent DJ, Nelson H: Postoperative surveillance recommendations for early stage colon cancer based on. J Clin Oncol 2009;27:3671–3676.

    Article  PubMed  Google Scholar 

  62. AWMF-Leitlinie: Histopathologische Diagnose der nicht-alkoholischen und alkoholischen Fettlebererkrankung. http://www.uni-duesseldorf.de/AWMF/ll/035-004m.htm

  63. El-Badry AM, Breitenstein S, Jochum W, Washington K, Paradis V, Rubbia-Brandt L, Puhan MA, Slankamenac K, Graf R, Clavien PA: Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 2009;250:691–697.

    Article  PubMed  Google Scholar 

  64. Patton HM, Lavine JE, Van NML, Schwimmer JB, Kleiner D, Molleston J: Clinical correlates of histopathology in pediatrie nonalcoholic steatohepatitis. Gastroenterology 2008, 135:1961–1971.e2.

    Article  PubMed  Google Scholar 

  65. Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, Shiehmorteza M, Yokoo T, Chavez A, Middleton MS, Sirlin CB: Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009,136:1585–1592.

    Article  PubMed  Google Scholar 

  66. Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, Bedossa P, Belghiti J: Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009;49:851–859.

    Article  PubMed  Google Scholar 

  67. Muratori P, Granito A, Pappas G, Pendino GM, Quarneti C, Cicola R, Menichella R, Ferri S, Cassani F, Bianchi FB, Lenzi M, Muratori L: The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Am J Gastroenterol 2009;104:1420–1425.

    Article  PubMed  Google Scholar 

  68. Neuhäuser M, Bjornsson E, Treeprasertsuk S, Enders F, Silveira M, Talwalkar J, Lindor K: Autoimmune Hepatitis-PBC Overlap Syndrome: A Simplified Scoring System May Assist in the Diagnosis. Am J Gastroenterol 2009.

    Google Scholar 

  69. Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, Heneghan MA: Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009;50:538–545.

    Article  PubMed  Google Scholar 

  70. Lewin M, Vilgrain V, Ozenne V, Lemoine M, Wendum D, Paradis V, Ziol M, Arrive L, Beaugrand M, Poupon R, Valla D, Chazouilleres O, Corpechot C: Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study. Hepatology 2009;50:528–537.

    Article  PubMed  Google Scholar 

  71. Myers RP, Shaheen AA, Fong A, Burak KW, Wan A, Swain MG, Hilsden RJ, Sutherland L, Quan H.: Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology. 2009 Dec;50:1884–92.

    Article  PubMed  Google Scholar 

  72. Fritcher EG, Kipp BR, Hailing KC, Oberg TN, Bryant SC, Tarrell RF, Gores GJ, Levy MJ, Clayton AC, Sebo TJ, Roberts LR: A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. Gastroenterology 2009, 136:2180–2186.

    Article  PubMed  Google Scholar 

  73. Hapani S, Chu D, Wu S: Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol 2009,10:559–568.

    Article  CAS  PubMed  Google Scholar 

  74. Chau I, Cunningham D: Bevacizumab-associated gastrointestinal perforation. Lancet Oncol 2009,10:534–536.

    Article  PubMed  Google Scholar 

  75. Holubar SD, Hassinger JP, Dozois EJ, Masuoka HC: Methamphetamine Colitis: A Rare Case of Ischemic Colitis in a Young Patient. Arch Surg 2009,144:780–782.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Medizin Verlag Heidelberg

About this paper

Cite this paper

Tannapfel, A. (2010). Pathologie. In: Eli, C., Layer, P., Fischbach, W., Zirngibl, H. (eds) Handbuch Gastroenterologie 2010. Handbuch Update-Seminar. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11635-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11635-3_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11634-6

  • Online ISBN: 978-3-642-11635-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics